Ozanezumab structure
|
Common Name | Ozanezumab | ||
|---|---|---|---|---|
| CAS Number | 1310680-64-8 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of OzanezumabOzanezumab (GSK1223249) is an anti-Nogo-A (neurite outgrowth inhibitor A) monoclonal antibody. Ozanezumab can be used in amyotrophic lateral sclerosis (ALS) and multiple sclerosis research[1]. |
| Name | Ozanezumab |
|---|
| Description | Ozanezumab (GSK1223249) is an anti-Nogo-A (neurite outgrowth inhibitor A) monoclonal antibody. Ozanezumab can be used in amyotrophic lateral sclerosis (ALS) and multiple sclerosis research[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |